Table 2.
Vaccine n (%) |
Placebo n (%) |
Total N (%) |
|
---|---|---|---|
Subjects screened for RT-PCR test | 405 | 135 | 540 |
Subjects screened for IgM/IgG test | 405 | 135 | 540 |
Subjects enrolled | 405 | 135 | 540 |
First vaccination completed | 405 | 135 | 540 |
Second vaccination completed | 397 | 133 | 530 |
Intention-to-treat population (for safety and efficacy analysis) | 405 | 135 | 540 |
Per-protocol population (for immunogenicity analysis 14 days after last injection) | 397 | 133 | 530 |